Skip to main content
  • Book
  • © 2010

Brain Protection in Schizophrenia, Mood and Cognitive Disorders

  • Neuroprotective strategies
  • Mechanisms of brain protection
  • Neuromodulation for neuropsychiatric disorders
  • Novel neuroprotective agents

Buy it now

Buying options

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (21 chapters)

  1. Front Matter

    Pages i-xv
  2. Neuroprotective Strategies and Mechanisms

    1. Front Matter

      Pages 1-1
    2. What Protects Patients with Schizophrenia from Developing Alzheimer Pathology?

      • Hans-Gert Bernstein, Theresia S. Ernst, Uwe Lendeckel, Henrik Dobrowolny, Johann Steiner, Bernhard Bogerts
      Pages 45-66
    3. One-Compound-Multi-Targets at Amyloid β Cascade Offered By Bis(7)-Cognitin, a Novel Anti-Alzheimer’s Dimer

      • Wenming Li, Hongjun Fu, Moussa B.H. Youdim, Yuanping Pang, Yifan Han
      Pages 165-183
    4. Common Pathways to Neurodegeneration and Co-morbid Depression

      • Darcy Litteljohn, Emily Mangano, Shawn Hayley
      Pages 185-241
    5. Oxidative Stress and Neurodegeneration: An Inevitable Consequence of Aging? Implications for Therapy

      • Roberto Rodrigues, David J. Bonda, George Perry, Rudy J. Castellani, Gemma Casadesus, Hyoung-gon Lee et al.
      Pages 305-323
    6. Carbon Nanotubes as Electrical Interfaces with Neurons

      • William Lee, Vladimir Parpura
      Pages 325-340
  3. Part II. Neuroprotective Treatment and Neuromodulation

    1. Front Matter

      Pages 341-341
    2. Recombinant Human Erythropoietin: Novel Approach to Neuroprotection and Neuroregeneration in Schizophrenia

      • Hannelore Ehrenreich, Claudia Bartels, Henning Krampe, Martin Begemann
      Pages 397-415
    3. Neuroprotective Agents in Mood Disorders: Pathophysiological and Therapeutic Implications

      • Giacomo Salvadore, Rodrigo Machado-Vieira, Husseini K. Manji
      Pages 417-449
    4. Neuroprotection in Bipolar Depression

      • Chris B. Aiken
      Pages 451-483
    5. The Neuroprotective Efficacy of Vitamins

      • Chanoch Miodownik, Vladimir Lerner
      Pages 505-553

About this book

Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to more efficacious treatment of major mental health disorders.

The book is divided into two sections. The first section serves as an introduction and overview of conceptual issues of the neuroprotective approach, and some neurobiological advances. Chapters in this section review definitions, perspectives, and issues that provide a conceptual base for the rest of the book. In addition, this part includes chapters in which the authors present and discuss the findings from basic studies of neurodegenerative mechanisms that are associated with the pathogenesis of major mental health disorders. The second section focuses on findings obtained from clinical trials with neuroprotective compounds, and neuromodulatory techniques. The take-home message is that principles of the neuroprotective approach may be applied to treatment of schizophrenia, mood and cognitive disorders. Contributors to this book are among the most active investigators and clinicians in the field who provide new perspectives not only clarifying ongoing controversies but also propose diverse aspects and new insights to neuroprotection.

This book is intended for a broad readership, which includes a broad spectrum of readers including neuroscientists, psychiatrists, neurologists, pharmacologists, clinical psychologists, general practitioners, geriatricians, graduate students, and policy makers in the fields of mental health.

Editors and Affiliations

  • Sha'ar Menashe Mental Health Center, Hadera, Israel

    Michael S. Ritsner

Bibliographic Information

Buy it now

Buying options

eBook USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access